DTL
ARIA

Dynamic Technology Lab’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Dynamic Technology Lab’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-25,342
Closed -$162K – 1351
2016
Q1 		$162K Buy
+25,342
New +$142K 0.04% 781
2014
Q1 		– Sell
-14,057
Closed -$96K – 825
2013
Q4 		$96K Buy
14,057
+470
+3% +$2.54K 0.07% 474
2013
Q3 		$250K Buy
+13,587
New +$264K 0.2% 229

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Dynamic Technology Lab's ARIA Position: Q2 2016 in Review

Dynamic Technology Lab sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2016, closing a stake of 25,342 shares — an estimated $162K sold.

Dynamic Technology Lab first reported a position in ARIA in Q3 2013 and held it in 3 quarters. The position peaked at $250K in Q3 2013. 182 funds tracked by Wall St. Rank hold ARIA as of Q2 2016.

  • Dynamic Technology Lab reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Dynamic Technology Lab sold 25,342 Ariad Pharmaceuticals Inc shares in Q2 2016, an estimated $162K.
  • Dynamic Technology Lab first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 3 quarters.
  • Dynamic Technology Lab's Ariad Pharmaceuticals Inc position peaked at $250K in Q3 2013.
  • 182 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2016.

Based on Dynamic Technology Lab's 13F filing for Q2 2016, filed 10 Aug 2016.